drug prices

Anti-cancer medicine prices: revised MRPs for 1,364 formulations took effect on 9 November after the NPPA capped trade margins at 30% of MRP.

India has capped trade margins on non-scheduled cancer medicines at 30 percent, with a revised list of 543 brands taking effect on 9 November 2026.

The Supreme Court reserved its verdict after questioning how a cancer injection costing a dealer Rs 11,000 could be charged to a patient at Rs 1.30 lakh.

The White House claimed the largest-ever decline in US prescription drug prices under TrumpRx, framing it as a defining domestic promise kept.